摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-氨基-2,3,5-三氯吡啶 | 28443-69-8

中文名称
4-氨基-2,3,5-三氯吡啶
中文别名
2,3,5-三氯-4-氨基吡啶;2,3,5-三氯-4-吡啶胺
英文名称
4-amino-2,3,5-trichloropyridine
英文别名
2,3,5-trichloro-pyridin-4-ylamine;2,3,5-Trichlor-[4]pyridylamin;4-Amino-2,3,5-trichlor-pyridin;2,3,5-Trichlor-4-aminopyridin;4-Amino-2,3,5-trichlorpyridin;2,3,5-Trichloropyridin-4-amine
4-氨基-2,3,5-三氯吡啶化学式
CAS
28443-69-8
化学式
C5H3Cl3N2
mdl
MFCD00153908
分子量
197.451
InChiKey
YYJDUYUWQJWYNA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    153-155 °C(lit.)
  • 沸点:
    294.4±35.0 °C(Predicted)
  • 密度:
    1.634±0.06 g/cm3(Predicted)
  • 溶解度:
    DMSO(少量)、甲醇(少量)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    38.9
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险品标志:
    Xn
  • 安全说明:
    S26,S36
  • 危险类别码:
    R20/21/22,R36/37/38
  • WGK Germany:
    3
  • 海关编码:
    2933399090
  • 危险性防范说明:
    P261,P280,P305+P351+P338
  • 危险性描述:
    H302+H312+H332,H315,H319,H335
  • 储存条件:
    2-8°C

SDS

SDS:1c9e3917049356f2acf0cdc07f26c6a3
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] PREPARATION OF HALOGEN ANALOGS OF PICLORAM<br/>[FR] PRÉPARATION D'ANALOGUES HALOGÉNÉS DE PICLORAM
    申请人:DOW AGROSCIENCES LLC
    公开号:WO2020061146A1
    公开(公告)日:2020-03-26
    Methods for preparing 5-fluoro-6-(bromo or chloro)picloram analogs, or derivatives thereof, from picloram acid, picloram ester, or the nitrile analog of picloram are provided. The methods include chemical process steps that: (1) introduce a phthaloyl group onto the 4-amino substituent of picloram acid, picloram ester, or the nitrile analog of picloram, (2) add 2 fluorine atoms at the 5,6-positions of the pyridine ring using halex fluorination chemistry, (3) remove the phthaloyl group, hydrolyze the ester or nitrile substituent, and add chlorine or bromine to the 6-position by treatment with an acid and water, and finally, (4) esterify the 5-fluoro-6-(bromo or chloro)picloram acid produced in step (3) to a 5-fluoro-6-(bromo or chloro)picloram ester.
    提供了从吡克洛拉姆酸、吡克洛拉姆酯或吡克洛拉姆的腈类似物制备5-氟-6-(溴或氯)吡克洛拉姆类似物或衍生物的方法。这些方法包括化学过程步骤:(1)将邻苯二甲酰基引入吡克洛拉姆酸、吡克洛拉姆酯或吡克洛拉姆的腈类似物的4-氨基取代物上,(2)使用哈莱克斯氟化化学在吡啶环的5,6-位置添加2个氟原子,(3)去除邻苯二甲酰基,水解酯或腈基取代物,并通过酸和水处理在6-位置添加氯或溴,最后,(4)将步骤(3)中产生的5-氟-6-(溴或氯)吡克洛拉姆酸酯化为5-氟-6-(溴或氯)吡克洛拉姆酯。
  • Synthesis of nitrogen-doped ZnO by sol—gel method: characterization and its application on visible photocatalytic degradation of 2,4-D and picloram herbicides
    作者:J. J. Macías-Sánchez、L. Hinojosa-Reyes、A. Caballero-Quintero、W. de la Cruz、E. Ruiz-Ruiz、A. Hernández-Ramírez、J. L. Guzmán-Mar
    DOI:10.1039/c4pp00273c
    日期:2015.3
    In this work, nitrogen-doped ZnO material was synthesized by the sol-gel method using zinc acetate as the precursor and urea as the nitrogen source (15, 20, 25 and 30% wt.). For comparative purposes, bare ZnO was also prepared. The influence of N doping on structural, morphological, optical and photocatalytic properties was investigated. The synthesized catalysts were characterized by XRD, SEM-EDS, diffuse reflectance UV-Vis spectroscopy, BET and XPS analysis. The photocatalytic activity of N-doped ZnO catalysts was evaluated during the degradation of a mixture of herbicides (2,4-D and picloram) under visible radiation ≥400 nm. The photo-absorption wavelength range of the N-doped ZnO samples was shifted to longer wavelength compared to those of the unmodified ZnO. Among different amounts of dopant agent, the 30% N-doped ZnO material showed higher visible-light activity compared with pure ZnO. Several degradation by-products were identified by using HPLC and ESI-MS/MS. The enhancement of visible photocatalytic activity of the N-doped ZnO semiconductor could be mainly due to their capability in reducing the electron-hole pair recombination.
    本工作以醋酸锌为前驱体,尿素为氮源(质量分数15%、20%、25%、30%),通过溶胶-凝胶法合成了氮掺杂ZnO材料。为了比较的目的,还制备了裸ZnO。研究了N掺杂对结构、形态、光学和光催化性能的影响。通过 XRD、SEM-EDS、漫反射紫外-可见光谱、BET 和 XPS 分析对合成的催化剂进行了表征。在≥400 nm的可见光辐射下,评估了除草剂(2,4-D和毒莠定)混合物的降解过程中N掺杂ZnO催化剂的光催化活性。与未修饰的 ZnO 相比,N 掺杂 ZnO 样品的光吸收波长范围移动到更长的波长。在不同掺杂剂用量下,30% N掺杂的ZnO材料与纯ZnO相比表现出更高的可见光活性。使用 HPLC 和 ESI-MS/MS 鉴定了几种降解副产物。 N掺杂ZnO半导体可见光催化活性的增强主要是由于其减少电子空穴对复合的能力。
  • Substituted aminodi- or trihalopyridines and method of use
    申请人:The Dow Chemical Company
    公开号:US04066438A1
    公开(公告)日:1978-01-03
    Novel compounds corresponding to the formula ##STR1## and the organic or inorganic acid addition salts thereof, wherein X represents chloro, bromo or fluoro; R.sup.1 represents hydrogen, amino, loweralkylamino, arylamino, loweralkylamido or N-(loweralkyl)loweralkylamido; R.sup.2 represents hydrogen, X, amino or loweralkylamino, with the proviso that one of R.sup.1 or R.sup.2 is always amino or loweralkylamino and the other of R.sup.1 or R.sup.2 is other than amino or loweralkylamino; R represents butyl, 2-hydroxypropyl, 4-hydroxybutyl, 6-hydroxyhexyl or the radical ##STR2## wherein Z represents amino, lower-alkylamino, phenylamino, hydroxy, loweralkoxy, aryloxy, 2-propenyl, hydroxyloweralkoxy, mercapto, loweralkylthio, loweralkanoyloxy or 2-haloloweralkanoyloxy and R.sup.3 represents hydrogen or methyl and with the proviso that R is other than butyl when R.sup.2 is X are prepared. These compounds are useful as herbicides and as active agents in compositions used as herbicides.
    本发明涉及符合以下式子的新化合物及其有机或无机酸盐衍生物,其中X代表氯、溴或氟;R.sup.1代表氢、氨基、低碳基氨基、芳基氨基、低碳基酰胺或N-(低碳基)低碳基酰胺基;R.sup.2代表氢、X、氨基或低碳基氨基,但其中一个R.sup.1或R.sup.2总是氨基或低碳基氨基,而另一个R.sup.1或R.sup.2则不是氨基或低碳基氨基;R代表丁基、2-羟基丙基、4-羟基丁基、6-羟基己基或基团##STR2##其中Z代表氨基、低碳基氨基、苯基氨基、羟基、低碳氧基、芳基氧基、2-丙烯基、羟基低碳氧基、巯基、低碳基硫醇、低碳酰氧或2-卤代低碳酰氧;R.sup.3代表氢或甲基,但有条件当R.sup.2为X时R不是丁基。这些化合物可用作除草剂,并作为除草剂配方中的活性成分。
  • BICYCLIC HETEROARYL INHIBITORS OF PDE4
    申请人:Govek Steven P.
    公开号:US20090291950A1
    公开(公告)日:2009-11-26
    The present invention relates to compounds and methods which may be useful as inhibitors of phosphodiesterase 4 (PD E4) for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators.
    本发明涉及化合物和方法,可用作磷酸二酯酶4(PDE4)的抑制剂,用于治疗或预防炎症性疾病和其他涉及细胞因子和促炎介质水平升高的疾病。
  • Preparation of halogen analogs of picloram
    申请人:Corteva Agriscience LLC
    公开号:US11401242B2
    公开(公告)日:2022-08-02
    Methods for preparing 5-fluoro-6-(bromo or chloro)picloram analogs, or derivatives thereof, from picloram acid, picloram ester, or the nitrile analog of picloram are provided. The methods include chemical process steps that: (1) introduce a phthaloyl group onto the 4-amino substituent of picloram acid, picloram ester, or the nitrile analog of picloram, (2) add 2 fluorine atoms at the 5,6-positions of the pyridine ring using halex fluorination chemistry, (3) remove the phthaloyl group, hydrolyze the ester or nitrile substituent, and add chlorine or bromine to the 6-position by treatment with an acid and water, and finally, (4) esterify the 5-fluoro-6-(bromo or chloro)picloram acid produced in step (3) to a 5-fluoro-6-(bromo or chloro)picloram ester.
    提供了从毒莠定酸、毒莠定酯或毒莠定的腈类似物制备 5-氟-6-(溴或氯)毒莠定类似物或其衍生物的方法。这些方法包括以下化学工艺步骤(1) 在毒莠定酸、毒莠定酯或毒莠定腈类似物的 4-氨基取代基上引入邻苯二甲酰基,(2) 使用哈来克斯氟化化学法在吡啶环的 5、6-位上添加 2 个氟原子,(3) 去除邻苯二甲酰基、(4) 将步骤(3)中生成的 5-氟-6-(溴或氯)毒莠定酸酯化为 5-氟-6-(溴或氯)毒莠定酯。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-